Katherine E. A. Semrau, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Delivery, Obstetric | 24 | 2023 | 906 | 4.890 |
Why?
|
Checklist | 19 | 2023 | 833 | 4.330 |
Why?
|
Parturition | 16 | 2022 | 441 | 3.620 |
Why?
|
Chlorhexidine | 7 | 2022 | 162 | 2.820 |
Why?
|
Infant Mortality | 16 | 2023 | 754 | 2.330 |
Why?
|
Maternal Health Services | 8 | 2022 | 455 | 2.290 |
Why?
|
World Health Organization | 12 | 2023 | 1318 | 2.090 |
Why?
|
Maternal Mortality | 12 | 2021 | 310 | 1.940 |
Why?
|
Perinatal Mortality | 8 | 2021 | 105 | 1.890 |
Why?
|
Zambia | 35 | 2023 | 261 | 1.870 |
Why?
|
Anti-Infective Agents, Local | 6 | 2021 | 250 | 1.820 |
Why?
|
Umbilical Cord | 5 | 2018 | 180 | 1.820 |
Why?
|
India | 19 | 2022 | 2197 | 1.610 |
Why?
|
Midwifery | 5 | 2020 | 132 | 1.440 |
Why?
|
Milk, Human | 13 | 2023 | 490 | 1.290 |
Why?
|
Oxytocin | 2 | 2021 | 394 | 1.200 |
Why?
|
Infant, Newborn | 51 | 2023 | 25625 | 1.170 |
Why?
|
Pregnancy | 51 | 2023 | 29144 | 1.100 |
Why?
|
Infant, Low Birth Weight | 5 | 2023 | 850 | 1.090 |
Why?
|
Guideline Adherence | 7 | 2021 | 2266 | 1.080 |
Why?
|
Perinatal Care | 2 | 2019 | 227 | 1.060 |
Why?
|
Breast Feeding | 19 | 2023 | 1338 | 0.980 |
Why?
|
Infectious Disease Transmission, Vertical | 15 | 2017 | 1320 | 0.840 |
Why?
|
Nurses | 2 | 2020 | 2461 | 0.720 |
Why?
|
Nurse Midwives | 1 | 2020 | 24 | 0.720 |
Why?
|
Nevirapine | 7 | 2013 | 267 | 0.690 |
Why?
|
Equipment and Supplies | 2 | 2019 | 281 | 0.690 |
Why?
|
Infant Formula | 1 | 2021 | 199 | 0.680 |
Why?
|
Breast Diseases | 2 | 2013 | 443 | 0.660 |
Why?
|
Evidence-Based Practice | 2 | 2020 | 500 | 0.640 |
Why?
|
HIV Infections | 31 | 2019 | 16718 | 0.630 |
Why?
|
Skin Diseases, Bacterial | 1 | 2018 | 66 | 0.610 |
Why?
|
Aftercare | 2 | 2022 | 866 | 0.610 |
Why?
|
Peer Group | 2 | 2020 | 635 | 0.610 |
Why?
|
Pregnant Women | 1 | 2022 | 568 | 0.580 |
Why?
|
Resuscitation | 1 | 2021 | 658 | 0.570 |
Why?
|
Program Evaluation | 5 | 2019 | 2488 | 0.540 |
Why?
|
Child Health Services | 2 | 2019 | 667 | 0.530 |
Why?
|
Developing Countries | 7 | 2023 | 2815 | 0.530 |
Why?
|
Quality of Health Care | 6 | 2022 | 4371 | 0.520 |
Why?
|
Infant | 37 | 2023 | 35136 | 0.520 |
Why?
|
Community Health Services | 2 | 2018 | 650 | 0.510 |
Why?
|
Quality Improvement | 12 | 2021 | 3749 | 0.500 |
Why?
|
Cesarean Section | 3 | 2022 | 1365 | 0.500 |
Why?
|
Obstetrics | 1 | 2021 | 658 | 0.490 |
Why?
|
Female | 85 | 2023 | 380194 | 0.460 |
Why?
|
Patient Acceptance of Health Care | 3 | 2023 | 3022 | 0.460 |
Why?
|
Emergency Treatment | 1 | 2017 | 517 | 0.460 |
Why?
|
Stillbirth | 3 | 2023 | 346 | 0.450 |
Why?
|
Infant, Premature | 2 | 2023 | 2044 | 0.420 |
Why?
|
RNA, Viral | 7 | 2013 | 2902 | 0.420 |
Why?
|
Pregnancy Complications | 4 | 2023 | 2861 | 0.420 |
Why?
|
Surgical Wound Infection | 1 | 2021 | 1540 | 0.410 |
Why?
|
Caregivers | 1 | 2023 | 2094 | 0.400 |
Why?
|
HIV-1 | 10 | 2017 | 6939 | 0.390 |
Why?
|
Birth Weight | 8 | 2023 | 2069 | 0.390 |
Why?
|
Weaning | 7 | 2010 | 105 | 0.380 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2015 | 2026 | 0.380 |
Why?
|
Patient Education as Topic | 2 | 2020 | 2278 | 0.370 |
Why?
|
Sepsis | 2 | 2021 | 2593 | 0.350 |
Why?
|
Prenatal Care | 4 | 2023 | 1092 | 0.340 |
Why?
|
Abscess | 1 | 2013 | 607 | 0.340 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2016 | 941 | 0.340 |
Why?
|
Humans | 93 | 2023 | 744343 | 0.330 |
Why?
|
Patient Care Team | 2 | 2016 | 2531 | 0.310 |
Why?
|
Adaptation, Psychological | 1 | 2018 | 2576 | 0.300 |
Why?
|
Malawi | 3 | 2023 | 282 | 0.300 |
Why?
|
Health Facilities | 4 | 2020 | 573 | 0.290 |
Why?
|
Mothers | 7 | 2023 | 2165 | 0.280 |
Why?
|
Bacterial Infections | 1 | 2015 | 1401 | 0.280 |
Why?
|
Puerperal Disorders | 2 | 2020 | 275 | 0.280 |
Why?
|
Counseling | 3 | 2019 | 1523 | 0.250 |
Why?
|
Chloroquine | 1 | 2006 | 280 | 0.250 |
Why?
|
Malaria | 4 | 2012 | 1239 | 0.250 |
Why?
|
Quality Indicators, Health Care | 4 | 2020 | 1831 | 0.250 |
Why?
|
Antimalarials | 3 | 2012 | 905 | 0.240 |
Why?
|
Postpartum Period | 4 | 2023 | 1086 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 9959 | 0.230 |
Why?
|
Cluster Analysis | 2 | 2021 | 2715 | 0.230 |
Why?
|
Anti-HIV Agents | 7 | 2013 | 4256 | 0.210 |
Why?
|
Tanzania | 2 | 2023 | 1346 | 0.190 |
Why?
|
Infant, Newborn, Diseases | 2 | 2018 | 582 | 0.190 |
Why?
|
Mastitis | 2 | 2013 | 41 | 0.190 |
Why?
|
Patient Discharge | 3 | 2022 | 3313 | 0.180 |
Why?
|
Thinness | 1 | 2023 | 480 | 0.170 |
Why?
|
Adult | 29 | 2021 | 214055 | 0.170 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2023 | 365 | 0.170 |
Why?
|
Depression, Postpartum | 1 | 2023 | 340 | 0.160 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2021 | 406 | 0.160 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2021 | 347 | 0.160 |
Why?
|
Community-Institutional Relations | 1 | 2019 | 204 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2019 | 3923 | 0.150 |
Why?
|
CD4 Lymphocyte Count | 7 | 2009 | 2559 | 0.150 |
Why?
|
Obstetric Labor Complications | 1 | 2020 | 238 | 0.150 |
Why?
|
HIV | 3 | 2009 | 1604 | 0.150 |
Why?
|
Information Seeking Behavior | 1 | 2018 | 113 | 0.150 |
Why?
|
Postnatal Care | 2 | 2018 | 236 | 0.140 |
Why?
|
Peer Review | 1 | 2019 | 209 | 0.140 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 426 | 0.140 |
Why?
|
Perception | 1 | 2023 | 1198 | 0.140 |
Why?
|
Africa South of the Sahara | 4 | 2022 | 724 | 0.130 |
Why?
|
Home Childbirth | 2 | 2013 | 51 | 0.130 |
Why?
|
Shame | 1 | 2015 | 78 | 0.130 |
Why?
|
Fetal Death | 1 | 2016 | 448 | 0.120 |
Why?
|
Polymerase Chain Reaction | 4 | 2013 | 6171 | 0.120 |
Why?
|
Viral Load | 6 | 2009 | 3299 | 0.120 |
Why?
|
Anti-Retroviral Agents | 3 | 2015 | 1715 | 0.120 |
Why?
|
Standard of Care | 1 | 2017 | 564 | 0.120 |
Why?
|
Anemia | 1 | 2023 | 1506 | 0.120 |
Why?
|
Rural Population | 5 | 2017 | 2210 | 0.120 |
Why?
|
Ethanolamines | 2 | 2012 | 158 | 0.120 |
Why?
|
Professional-Patient Relations | 1 | 2019 | 737 | 0.110 |
Why?
|
Neonatal Screening | 1 | 2017 | 591 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 639 | 0.110 |
Why?
|
Fluorenes | 2 | 2012 | 160 | 0.110 |
Why?
|
HIV Seropositivity | 4 | 2013 | 971 | 0.110 |
Why?
|
Health Care Surveys | 2 | 2017 | 2453 | 0.110 |
Why?
|
Research Design | 3 | 2017 | 5987 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1125 | 0.110 |
Why?
|
Hypothermia | 1 | 2014 | 189 | 0.110 |
Why?
|
Public Health Administration | 1 | 2015 | 240 | 0.110 |
Why?
|
Child Abuse, Sexual | 1 | 2015 | 383 | 0.110 |
Why?
|
Health Services Research | 2 | 2017 | 1836 | 0.110 |
Why?
|
Artemisinins | 2 | 2012 | 221 | 0.100 |
Why?
|
Prospective Studies | 9 | 2023 | 53288 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2017 | 914 | 0.100 |
Why?
|
Gestational Age | 2 | 2017 | 3493 | 0.100 |
Why?
|
Reproductive Health Services | 1 | 2012 | 80 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7279 | 0.100 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3508 | 0.100 |
Why?
|
Medication Adherence | 2 | 2015 | 2063 | 0.100 |
Why?
|
Communications Media | 1 | 2011 | 43 | 0.100 |
Why?
|
Health Behavior | 2 | 2018 | 2636 | 0.100 |
Why?
|
Neglected Diseases | 1 | 2011 | 64 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2016 | 1462 | 0.090 |
Why?
|
Stereotyping | 1 | 2012 | 241 | 0.090 |
Why?
|
Mass Screening | 3 | 2019 | 5255 | 0.090 |
Why?
|
Vietnam | 3 | 2019 | 408 | 0.090 |
Why?
|
Health Services Accessibility | 3 | 2017 | 5137 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2019 | 6365 | 0.090 |
Why?
|
Cohort Studies | 8 | 2021 | 40561 | 0.090 |
Why?
|
Desiccation | 1 | 2009 | 70 | 0.090 |
Why?
|
Culture | 1 | 2013 | 633 | 0.090 |
Why?
|
Parents | 1 | 2023 | 3407 | 0.090 |
Why?
|
Interleukin-15 | 1 | 2009 | 184 | 0.080 |
Why?
|
Pneumonia, Bacterial | 1 | 2012 | 316 | 0.080 |
Why?
|
Drug Combinations | 3 | 2012 | 1959 | 0.080 |
Why?
|
Algorithms | 3 | 2018 | 13881 | 0.080 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 1971 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19905 | 0.080 |
Why?
|
Prejudice | 1 | 2012 | 570 | 0.080 |
Why?
|
Male | 16 | 2022 | 350118 | 0.080 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2010 | 314 | 0.080 |
Why?
|
Asia | 2 | 2021 | 610 | 0.080 |
Why?
|
Health Personnel | 1 | 2021 | 3218 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7785 | 0.080 |
Why?
|
Child | 6 | 2023 | 77709 | 0.070 |
Why?
|
Parity | 3 | 2023 | 929 | 0.070 |
Why?
|
Leadership | 1 | 2016 | 1357 | 0.070 |
Why?
|
Interleukin-7 | 1 | 2007 | 142 | 0.070 |
Why?
|
Domestic Violence | 2 | 2006 | 176 | 0.070 |
Why?
|
Blood | 1 | 2009 | 598 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2212 | 0.070 |
Why?
|
Specimen Handling | 2 | 2009 | 694 | 0.070 |
Why?
|
Public Sector | 2 | 2018 | 265 | 0.070 |
Why?
|
Sulfadoxine | 1 | 2006 | 49 | 0.070 |
Why?
|
Logistic Models | 2 | 2020 | 13408 | 0.070 |
Why?
|
Time Factors | 6 | 2016 | 40075 | 0.070 |
Why?
|
Genotype | 3 | 2017 | 12951 | 0.070 |
Why?
|
Pyrimethamine | 1 | 2006 | 97 | 0.070 |
Why?
|
alpha-Defensins | 1 | 2005 | 28 | 0.070 |
Why?
|
Internationality | 1 | 2011 | 1003 | 0.070 |
Why?
|
Risk Factors | 7 | 2021 | 72290 | 0.060 |
Why?
|
Divorce | 1 | 2005 | 79 | 0.060 |
Why?
|
DNA, Viral | 2 | 2009 | 2225 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 25043 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14722 | 0.060 |
Why?
|
Risk Assessment | 4 | 2021 | 23338 | 0.060 |
Why?
|
Attitude to Health | 1 | 2013 | 2052 | 0.060 |
Why?
|
Prolactin | 1 | 2006 | 669 | 0.060 |
Why?
|
Patient Compliance | 4 | 2009 | 2684 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1177 | 0.060 |
Why?
|
Health Status | 1 | 2016 | 4034 | 0.060 |
Why?
|
Lactation | 1 | 2005 | 412 | 0.060 |
Why?
|
Fever | 1 | 2010 | 1616 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1917 | 0.050 |
Why?
|
Treatment Refusal | 1 | 2006 | 421 | 0.050 |
Why?
|
Sodium | 1 | 2008 | 1623 | 0.050 |
Why?
|
Pneumonia | 2 | 2011 | 2133 | 0.050 |
Why?
|
Infant Care | 2 | 2014 | 183 | 0.050 |
Why?
|
Family | 1 | 2012 | 3147 | 0.050 |
Why?
|
Young Adult | 6 | 2021 | 56430 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 204 | 0.050 |
Why?
|
Hospitals | 1 | 2014 | 3952 | 0.050 |
Why?
|
Infant, Small for Gestational Age | 1 | 2023 | 440 | 0.050 |
Why?
|
Violence | 1 | 2006 | 909 | 0.040 |
Why?
|
Family Characteristics | 1 | 2005 | 1000 | 0.040 |
Why?
|
Case Management | 2 | 2012 | 286 | 0.040 |
Why?
|
Survival Analysis | 2 | 2010 | 10252 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4328 | 0.040 |
Why?
|
Disclosure | 1 | 2005 | 736 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15540 | 0.040 |
Why?
|
Adolescent | 6 | 2021 | 85781 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2004 | 865 | 0.040 |
Why?
|
Mortality | 1 | 2010 | 2864 | 0.040 |
Why?
|
Child Abuse | 1 | 2006 | 1030 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1534 | 0.040 |
Why?
|
Mexico | 1 | 2019 | 690 | 0.040 |
Why?
|
Administration, Topical | 1 | 2018 | 690 | 0.030 |
Why?
|
Qualitative Research | 2 | 2019 | 2682 | 0.030 |
Why?
|
Spouses | 1 | 2018 | 286 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1531 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2016 | 63114 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1774 | 0.030 |
Why?
|
Nutritional Status | 1 | 2023 | 1609 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2017 | 456 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 2019 | 525 | 0.030 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2014 | 57 | 0.030 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 370 | 0.030 |
Why?
|
Risk-Taking | 1 | 2019 | 986 | 0.030 |
Why?
|
Rural Health | 1 | 2014 | 305 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 676 | 0.030 |
Why?
|
Body Temperature Regulation | 1 | 2014 | 252 | 0.030 |
Why?
|
Reproductive Rights | 1 | 2012 | 35 | 0.030 |
Why?
|
Women's Rights | 1 | 2012 | 69 | 0.030 |
Why?
|
Public Health | 2 | 2018 | 2603 | 0.030 |
Why?
|
Personnel, Hospital | 1 | 2014 | 283 | 0.030 |
Why?
|
Child, Preschool | 5 | 2014 | 41006 | 0.030 |
Why?
|
Health Promotion | 1 | 2004 | 2205 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2019 | 1240 | 0.020 |
Why?
|
Amoxicillin | 1 | 2012 | 170 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2795 | 0.020 |
Why?
|
Genes, env | 1 | 2010 | 95 | 0.020 |
Why?
|
HIV Envelope Protein gp160 | 1 | 2010 | 99 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2019 | 2057 | 0.020 |
Why?
|
Human Rights | 1 | 2012 | 307 | 0.020 |
Why?
|
HIV-2 | 1 | 2010 | 167 | 0.020 |
Why?
|
Measles | 1 | 2011 | 168 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2010 | 459 | 0.020 |
Why?
|
Gene Products, env | 1 | 2010 | 263 | 0.020 |
Why?
|
Contraception | 1 | 2012 | 359 | 0.020 |
Why?
|
Efficiency | 1 | 2012 | 462 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2002 | 4479 | 0.020 |
Why?
|
AIDS Serodiagnosis | 1 | 2009 | 184 | 0.020 |
Why?
|
Rural Health Services | 1 | 2012 | 379 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2009 | 6895 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2010 | 758 | 0.020 |
Why?
|
Focus Groups | 1 | 2012 | 1321 | 0.020 |
Why?
|
Infant Food | 1 | 2007 | 141 | 0.020 |
Why?
|
Efficiency, Organizational | 1 | 2012 | 695 | 0.020 |
Why?
|
Home Care Services | 1 | 2013 | 606 | 0.020 |
Why?
|
Abortion, Induced | 1 | 2012 | 458 | 0.020 |
Why?
|
Public Policy | 1 | 2011 | 572 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2010 | 1005 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2010 | 1723 | 0.020 |
Why?
|
Food Microbiology | 1 | 2006 | 78 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2008 | 793 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2009 | 21746 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.020 |
Why?
|
Poverty Areas | 1 | 2006 | 275 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2012 | 1411 | 0.020 |
Why?
|
Water Supply | 1 | 2006 | 214 | 0.020 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 615 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2009 | 1184 | 0.010 |
Why?
|
Diarrhea | 1 | 2011 | 1348 | 0.010 |
Why?
|
Alcohol-Related Disorders | 1 | 2006 | 234 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5078 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1856 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8388 | 0.010 |
Why?
|
Maternal Age | 1 | 2006 | 802 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2018 | 77449 | 0.010 |
Why?
|
Freezing | 1 | 2003 | 303 | 0.010 |
Why?
|
Social Support | 1 | 2012 | 2118 | 0.010 |
Why?
|
Data Collection | 1 | 2012 | 3341 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2002 | 329 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2886 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2011 | 2232 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 2010 | 39050 | 0.010 |
Why?
|
Age Factors | 2 | 2012 | 18370 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
Truth Disclosure | 1 | 2006 | 436 | 0.010 |
Why?
|
Proviruses | 1 | 2003 | 318 | 0.010 |
Why?
|
Epitope Mapping | 1 | 2002 | 311 | 0.010 |
Why?
|
Child Behavior Disorders | 1 | 2006 | 807 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3772 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7729 | 0.010 |
Why?
|
Urban Population | 1 | 2009 | 2021 | 0.010 |
Why?
|
Fear | 1 | 2009 | 1440 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4687 | 0.010 |
Why?
|
Decision Making | 1 | 2012 | 3887 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12797 | 0.010 |
Why?
|
Tuberculosis | 1 | 2011 | 1912 | 0.010 |
Why?
|
Health Education | 1 | 2004 | 1056 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2002 | 1880 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6538 | 0.010 |
Why?
|
Women's Health | 1 | 2006 | 2034 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2005 | 2258 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 1366 | 0.010 |
Why?
|
Middle Aged | 3 | 2014 | 213383 | 0.010 |
Why?
|
Viral Proteins | 1 | 2002 | 1900 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12354 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6544 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2002 | 3206 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7181 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2006 | 3748 | 0.010 |
Why?
|
Odds Ratio | 1 | 2006 | 9849 | 0.010 |
Why?
|
Sex Factors | 1 | 2006 | 10397 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16365 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12245 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13815 | 0.010 |
Why?
|
Peptides | 1 | 2002 | 4409 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 15076 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 18111 | 0.010 |
Why?
|
Incidence | 1 | 2006 | 20947 | 0.000 |
Why?
|
Aging | 1 | 2005 | 8664 | 0.000 |
Why?
|
Hospitalization | 1 | 2005 | 10262 | 0.000 |
Why?
|
Prognosis | 1 | 2005 | 29063 | 0.000 |
Why?
|
Aged | 1 | 2013 | 163280 | 0.000 |
Why?
|